About: Oliver Ottmann

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Oliver Ottmann Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

German researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) ikertzailea (eu) 연구원 (ko) ricercatore (it) গবেষক (bn) 研究者 (ja) ഗവേഷകൻ (ml) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) изилдөөчү (ky) 研究者 (zh) deutscher Arzt (de) հետազոտող (hy) hulumtues (sq) German researcher (en) باحث ألماني (ar)
rdfs:label	Oliver Ottmann (de) Oliver Ottmann (en) Oliver Ottmann (es) Oliver Ottmann (fr) Oliver Ottmann (nl) Oliver Ottmann (sl) Oliver Ottmann (ast) Oliver Ottmann (bar)
skos:prefLabel	Oliver Ottmann (de) Oliver Ottmann (en) Oliver Ottmann (es) Oliver Ottmann (fr) Oliver Ottmann (nl) Oliver Ottmann (sl) Oliver Ottmann (ast) Oliver Ottmann (bar)
name	Oliver Ottmann (de) Oliver Ottmann (en) Oliver Ottmann (es) Oliver Ottmann (fr) Oliver Ottmann (nl) Oliver Ottmann (sl) Oliver Ottmann (ast) Oliver Ottmann (bar)
given name	wds:Q39749891-D8FDDE21-AE8D-4A0F-94EF-6BADA4E4953E
given name	Oliver
instance of	wds:Q39749891-009612AD-C700-4D0C-8193-13172ACA33DD
instance of	Homo sapiens
skos:altLabel	Oliver G. Ottmann (de) Oliver G. Ottmann (en)
occupation	wds:Q39749891-EE1A47E0-A71F-4113-98DF-2B0DF0DD8842
languages spoken, written or signed	wds:Q39749891-428f1801-4b9d-58bd-8ed7-b21f13380001
sex or gender	wds:Q39749891-55FF172D-921B-472C-9F50-39C424588027
VIAF ID	wds:Q39749891-4D471718-4A4D-4DDE-9AAC-49B803DE84BE
GND ID	wds:q39749891-a5a82570-4659-48a7-f829-0363bba36565
country of citizenship	wds:Q39749891-b361836f-4842-d139-1e47-d941effca522
family name	wds:Q39749891-8380871a-42d5-b42c-39d5-b5fab5ad5839
WorldCat Identities ID (superseded)	wds:Q39749891-7F4DD646-6A85-4D4C-9452-A79766C668C9
VIAF ID	http://viaf.org/viaf/316532117
GND ID	https://d-nb.info/gnd/1073558401
occupation	researcher
languages spoken, written or signed	German
sex or gender	male
VIAF ID	316532117
GND ID	1073558401
country of citizenship	Germany
family name	Ottmann
WorldCat Identities ID (superseded)	viaf-316532117
ORCID iD	wds:Q39749891-90218C24-51E3-493D-8656-26130307F774
ORCID iD	https://orcid.org/0000-0001-9559-1330
ORCID iD	0000-0001-9559-1330
ResearcherID	wds:Q39749891-92C37948-0146-4FCE-BE6C-D55E57A893BB
Publons author ID	wds:Q39749891-ddda49ec-77aa-4859-8b64-da926ec3b214
ResearcherID	D-5007-2016
Publons author ID	2296281
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q39749891
is author of	Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study Changes in the haematopoietic progenitor cell compartment in the acquired immunodeficiency syndrome Polo-like kinases in AML. Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leukemias after imatinib resistance or intolerance Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL). An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR. Targeting the phosphoinositide 3-kinase pathway in hematologic malignancies Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells. Transcriptional profiling of human hematopoiesis during in vitro lineage-specific differentiation. IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21 Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival. Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial. Oligomerization inhibition, combined with allosteric inhibition, abrogates the transformation potential of T315I-positive BCR/ABL. Targeting of the N-terminal coiled coil oligomerization interface of BCR interferes with the transformation potential of BCR-ABL and increases sensitivity to STI571. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software